Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tonini

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|October 7, 2008
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastomaC Perfumo, S Parodi, K Mazzocco, et al.
British Journal of Cancer|March 29, 2000
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomasA Iolascon, L Giordani, A Borriello, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 1, 1991
N-myc oncogene amplification in a pediatric case of glioblastoma multiformeA M Stenger, M L Garrè, A Cama, et al.
Pediatric Research|January 1, 1990
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-mycP Cornaglia-Ferraris, M Ponzoni, P Montaldo, et al.
Oncogene|January 25, 2000
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradationA Borriello, V D Pietra, M Criscuolo, et al.
Cell Death and Differentiation|February 23, 2002
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patientsI Casciano, K Mazzocco, L Boni, et al.
Anticancer Research|July 1, 1990
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patientsM V Corrias, P Cornaglia-Ferraris, D Di Martino, et al.
Pediatric Research|February 12, 1998
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastomaA Iolascon, L Giordani, A Moretti, et al.
Medical and Pediatric Oncology|January 1, 1982
Immune evaluation of 50 children with neuroblastoma at onsetC Rosanda, B De Bernardi, M Pasino, et al.
Oncogene|July 20, 2007
Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cellsV S Budhram-Mahadeo, S Irshad, S Bowen, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|October 7, 2008
Impact of MDM2 SNP309 genotype on progression and survival of stage 4 neuroblastomaC Perfumo, S Parodi, K Mazzocco, et al.
British Journal of Cancer|March 29, 2000
Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomasA Iolascon, L Giordani, A Borriello, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|November 1, 1991
N-myc oncogene amplification in a pediatric case of glioblastoma multiformeA M Stenger, M L Garrè, A Cama, et al.
Pediatric Research|January 1, 1990
A new human highly tumorigenic neuroblastoma cell line with undetectable expression of N-mycP Cornaglia-Ferraris, M Ponzoni, P Montaldo, et al.
Oncogene|January 25, 2000
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradationA Borriello, V D Pietra, M Criscuolo, et al.
Cell Death and Differentiation|February 23, 2002
Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patientsI Casciano, K Mazzocco, L Boni, et al.
Anticancer Research|July 1, 1990
Expression of multiple drug resistance gene, MDR1, and N-myc oncogene in an Italian population of human neuroblastoma patientsM V Corrias, P Cornaglia-Ferraris, D Di Martino, et al.
Pediatric Research|February 12, 1998
Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastomaA Iolascon, L Giordani, A Moretti, et al.
Medical and Pediatric Oncology|January 1, 1982
Immune evaluation of 50 children with neuroblastoma at onsetC Rosanda, B De Bernardi, M Pasino, et al.
Oncogene|July 20, 2007
Proliferation-associated Brn-3b transcription factor can activate cyclin D1 expression in neuroblastoma and breast cancer cellsV S Budhram-Mahadeo, S Irshad, S Bowen, et al.
Pageof 8